Criteria | Recommendation for certification/award |
Any of the three incidence estimates* higher than 10% of the baseline estimate | Not recommended under any category |
At least two of the three-point estimates of decline in incidence support claimed category and none of the incidence estimates shows an increase from baseline incidence | Recommended under eligible/claimed category |
At least two of the three-point estimates of decline in incidence support claimed category and the other point estimate of incidence shows an increase of up to 10% from baseline incidence | If lower bound of the incidence estimate is more than 10% of the baseline estimate, then not recommended for any category. Else recommended under claimed category |
At least two of the three-point estimates of decline in incidence support higher than the claimed category | If lower bounds of CIs of those estimates of decline in incidence are found to support higher category, recommended under higher category |
All three incidence estimates are <44/100 000 population | Tuberculosis (TB)-free status for that year |
*The three estimates refer to the decline in the incidence of TB between 2015 and 2020 calculated using the TB incidence in 2020 calculated by direct, indirect and drug data-based methods.